UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 1.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,548,725 shares of the financial services provider’s stock after purchasing an additional 68,579 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.66% of MetLife worth $375,179,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. MeadowBrook Investment Advisors LLC raised its position in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after buying an additional 220 shares during the period. Carmichael Hill & Associates Inc. raised its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares during the period. Wolff Wiese Magana LLC raised its position in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares during the period. Peterson Financial Group Inc. purchased a new stake in shares of MetLife during the 3rd quarter valued at approximately $30,000. Finally, Fortitude Family Office LLC raised its position in shares of MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after buying an additional 266 shares during the period. Hedge funds and other institutional investors own 89.81% of the company’s stock.
MetLife Stock Up 0.6 %
MetLife stock opened at $88.25 on Friday. MetLife, Inc. has a twelve month low of $62.89 and a twelve month high of $89.05. The stock’s fifty day simple moving average is $83.19 and its 200-day simple moving average is $76.46. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $61.11 billion, a P/E ratio of 17.79, a P/E/G ratio of 0.81 and a beta of 1.05.
MetLife Announces Dividend
Analysts Set New Price Targets
Several analysts have recently commented on the stock. Barclays reduced their price target on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. Bank of America reduced their price target on shares of MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. Piper Sandler boosted their target price on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a research report on Monday. Finally, Wells Fargo & Company boosted their target price on MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Fourteen analysts have rated the stock with a buy rating, According to data from MarketBeat, MetLife currently has an average rating of “Buy” and an average price target of $88.62.
Read Our Latest Analysis on MET
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- 3 Tickers Leading a Meme Stock Revival
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Using the MarketBeat Dividend Yield Calculator
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.